Pancreatic Cancer Research

ResearcherComprehensive Cancer Center ViennaNo recent work listed

Michael Gnant

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1002-2118; OpenAlex author ID A5025718393. Sources: ClinicalTrials.gov.

Their work

Papers
8 (first author 0, last author 2)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
1
Collaborators
16
Papers, trials and grants by year

2007: 1 trial · 2008: none · 2009: none · 2010: none · 2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 3 papers

Papers 8

  1. Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection. Co-author DOI 10.1007/s11605-019-04187-z↗
  2. The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection. Co-author DOI 10.1245/s10434-019-08161-6↗
  3. Correction to: The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection. Co-author DOI 10.1245/s10434-020-09010-7↗
  4. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1371/journal.pone.0215915↗
  5. Preparing for prospective clinical trials: a national initiative of an excellence registry for consecutive pancreatic cancer resections. Co-author DOI 10.1007/s00268-013-2283-3↗
  6. A phase II trial of two durations of Bevacizumab added to neoadjuvant gemcitabine for borderline and locally advanced pancreatic cancer. Last author PMID 24778046↗
  7. Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features. Co-author DOI 10.1111/eci.12042↗
  8. NeoGemTax: gemcitabine and docetaxel as neoadjuvant treatment for locally advanced nonmetastasized pancreatic cancer. Last author DOI 10.1007/s00268-011-1113-8↗

Trials 1

  1. Reconstruction Method and Delayed Gastric Emptying After Pancreatic Surgery Principal investigator NCT01248663↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Klaus Sahora · 7 shared papers, 2011–2020 · strength 0.62
  2. Martin Schindl · 7 shared papers, 2011–2020 · strength 0.62
  3. Gerd Jomrich · 4 shared papers, 2019–2020 · strength 0.51
  4. Elisabeth S. Gruber · 4 shared papers, 2019–2020 · strength 0.51
  5. Ahmed Ba‐Ssalamah · 1 shared paper, 2014 · strength 0.04
  6. Gregor Werba · 1 shared paper, 2014 · strength 0.04
  7. Odo Gangl · 1 shared paper, 2014 · strength 0.04
  8. R. Függer · 1 shared paper, 2014 · strength 0.04
  9. Florian Primavesi · 1 shared paper, 2014 · strength 0.04
  10. Peter Kornprat · 1 shared paper, 2014 · strength 0.04
  11. Nigel Mackman · 1 shared paper, 2013 · strength 0.03
  12. Werner Scheithauer · 1 shared paper, 2013 · strength 0.03
  13. Ingrid Pabinger · 1 shared paper, 2013 · strength 0.03
  14. J. Thaler · 1 shared paper, 2013 · strength 0.03
  15. Cihan Ay · 1 shared paper, 2013 · strength 0.03
  16. Claus Koelblinger · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.